NCT04973189View on ClinicalTrials.gov

A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 8, 2021

Primary Completion Date

January 13, 2022

Study Completion Date

January 13, 2022

Conditions
Alzheimer's Disease
Interventions
DRUG

SHR-1707

A single dose of SHR-1707 by intravenous (IV) infusion in healthy young adults.

DRUG

Placebo

A single dose of matching SHR-1707 placebo by intravenous (IV) infusion in healthy young adults.

DRUG

SHR-1707

A single dose of SHR-1707 by intravenous (IV) infusion in elderly subjects.

DRUG

Placebo

A single dose of matching SHR-1707 placebo by intravenous (IV) infusion in elderly subjects.

Trial Locations (1)

230601

The second Hospital of Anhui Medical University, Hefei

All Listed Sponsors
lead

Shanghai Hengrui Pharmaceutical Co., Ltd.

INDUSTRY